Intradermal zoster vaccines: good for the old and the young?

Affiliations

¹ University of Antwerp, Antwerpen, Belgium.
² University of Antwerp, Antwerpen, Belgium; Center for Statistics, Hasselt University, Martelarenlaan 42, Hasselt, 3500, Belgium. Electronic address: niel.hens@uhasselt.be.

Comment

Benson Ogunjimi et al. Lancet Infect Dis. 2016 Aug.

. 2016 Aug;16(8):869-71.

doi: 10.1016/S1473-3099(16)00174-2. Epub 2016 Apr 6.

¹ University of Antwerp, Antwerpen, Belgium.
² University of Antwerp, Antwerpen, Belgium; Center for Statistics, Hasselt University, Martelarenlaan 42, Hasselt, 3500, Belgium. Electronic address: niel.hens@uhasselt.be.

No abstract available

Comment on

Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial.
Beals CR, Railkar RA, Schaeffer AK, Levin Y, Kochba E, Meyer BK, Evans RK, Sheldon EA, Lasseter K, Lang N, Weinberg A, Canniff J, Levin MJ. Beals CR, et al. Lancet Infect Dis. 2016 Aug;16(8):915-22. doi: 10.1016/S1473-3099(16)00133-X. Epub 2016 Apr 6. Lancet Infect Dis. 2016. PMID: 27061887 Clinical Trial.